Lian-Ping He Selected Research

Hemoglobins (Hemoglobin)

12/2013

Overweight and obesity associated with increased total serum calcium level: comparison of cross-sectional data in the health screening for teaching faculty.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lian-Ping He Research Topics

Disease

3	Obesity 05/2022 - 12/2013
2	Neoplasms (Cancer) 01/2021 - 01/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Asthma (Bronchial Asthma) 02/2015
1	Female Infertility 01/2015
1	Squamous Cell Carcinoma of Head and Neck 01/2014
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Overweight 12/2013
1	Ischemic Stroke 10/2013

Drug/Important Bio-Agent (IBA)

1	Glutathione (Reduced Glutathione)IBA 05/2022
1	TeaIBA 05/2022
1	CardenolidesIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	GlycosidesIBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	alanylalanine (Ala-Ala)IBA 06/2015
1	prolyl-proline (Pro-Pro)IBA 06/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2015
1	Immunoglobulin E (IgE)IBA 02/2015
1	InterferonsIBA 02/2015
1	Growth Hormone (Somatotropin)IBA 01/2015
1	ZincIBA 01/2014
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2014
1	EndopeptidasesIBA 01/2014
1	Hemoglobins (Hemoglobin)IBA 12/2013
1	ORALIT (ORS)IBA 12/2013
1	Triglycerides (Triacylglycerol)IBA 12/2013
1	CholesterolIBA 12/2013
1	CalciumIBA 12/2013
1	LDL CholesterolIBA 12/2013
1	HDL CholesterolIBA 12/2013
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2013

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 05/2022
1	Chemoradiotherapy 01/2021